Sante Ventures

Santé Ventures, based in Austin, Texas, is a leading venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors. Since its founding in 2006, the firm has raised over $800 million across multiple funds and primarily focuses on biotech, medtech, and healthtech companies that aim to deliver better patient outcomes at lower costs. Their strategy is to identify and support groundbreaking innovations in biology, medicine, and healthcare technologies, often leading or co-leading seed and Series A funding rounds. Santé has built a reputation for being an active investor, frequently becoming the first institutional backer of startups or even helping to create new companies from scratch. The firm’s portfolio includes high-impact companies like Molecular Templates, Claret Medical, and AbVitro, which have seen successful exits through acquisitions by major healthcare players like Boston Scientific, Celgene, and IBM. Their ability to spot potential early has led to a strong track record of performance, marked by 76 investments and 13 notable exits. In 2021, Santé raised $260 million for its fourth fund, which is focused on supporting 15-25 companies in the biotech, medtech, and healthtech sectors. With offices in both Austin and Boston, Santé continues to leverage its deep expertise in healthcare to identify transformative technologies that can reshape the industry and improve patient lives on a global scale. The firm’s disciplined approach ensures consistent returns, making it a key player in the life sciences venture capital ecosystem.